Cáncer de seno desde la nueva perspective PEM: Mamografía molecular
Galenus - Revista Para Los Médicos de Puerto Rico
El Dr. Jorge R. Toro Rámirez del Centro Sononuclear en Rio Piedras, P.R. sobre como PEM le ayuda evitar biopsias, cirujias y ansiedades innecesarias a pacientes y médicos.
Naviscan's EU launch featured as part of BIOCOM Inside Perspectives series
BIOCOM's Inside Perspective video series features local biotechnology, medical device, diagnostic and digital health leaders. It is an online forum for mid-level executives to share their knowledge and experience on a particular topic with their colleagues.
FDG dose can be reduced in Positron Emission Mammography
Recent studies presented at the ECR meeting in Vienna show that the FDG dose used in Positron Emission Mammography (PEM) may be reduced by up to 50% without impacting sensitivity.
The technology shows promise for initial staging of breast cancer, evaluating response to therapy, recurrence, and restaging.
Jupiter Medical Center Comprehensive Breast Care Program
Positron Emission Mammography will soon be available in Jupiter, Florida.
Ecuador cuenta con el primer Centro Integral de Medicine Nuclear y Molecular
El nuevo centro, que cuenta con instalaciones modernas y equipos de última tecnología como el Pet–Ct, Pem y Ciclotron Radio farmacia, permitirá que los especialistas realicen el diagnóstico temprano.
Palos Offers New Technology in the Fight Against Breast Cancer
Once again, Palos Community Hospital offers patients the most advanced technology in breast cancer detection with positron emission mammography, or PEM. It is one of only two PEM scanners in the Chicagoland area.
El PEM de Naviscan ocupará un lugar cada vez más relevante en las Unidades de Mama
Sociedad Española de Senología y Patología Mamaria - Noticias de interés
En esta edición del Congreso de la SESPM, y por primera vez en España presentamos el PEM (Positron Emission Mammography) de NAVISCAN. Se trata del primer PET específico de Mama de resultados confirmados desde hace muchos años en EEUU y el único que cuenta con la aprobación de la FDA.
Surviving Breast Cancer - With Help From PEM
A 72 year-old patient underwent PEM at Sightline West Houston prior to partial breast irradiation to confirm extent of disease. See interview with her radiation oncologist Dr. Noah Taylor from Century Cancer Centers.
The ROI of PEM
Dr. Kathy Schilling details study results demonstrating how PEM not only is a useful tool for our patients and physicians that attracts new business to the hospital, but it also may save health care dollars when compared to breast MRI.
Tendencias de la medicina nuclear en oncología
Dr. Enrique Estrada Lobato, jefe de Medicina Nuclear del Instituto Nacional de Cancerología de México discuta como la tomografía por emisión de positrones dedicada a mama (PEM) esta mejor para las primeras etapas del cáncer porque los detectores están en contacto con la glándula mamaria, y al fijarla con suavidad, permite alcanzar las resoluciones necesarias para visualizar lesiones de 1,5 milímetros de tamaño. Este exámen hace que se pueda diagnosticar de manera temprana el cáncer, estadificar y hacer la evaluación posterior al seguimiento.
Imágenes mamarias más que un estudio radiológico
Dra. Yolanda Villaseñor Navarro, directora del departamento de imagen del instituto Nacional de Cancerología de México discuta los avances tecnológicos incluyendo PEM.
The Future of Breast Cancer Care
The advanced imaging capabilities offered by University Radiology Associates, LLP, allow the imaging center to provide a superior level of care for a broad range of conditions. One of the most notable imaging services offered by the center is positron emission mammography (PEM).
Positron Emission Mammography Benefits
Positron emission mammography increases the specificity of breast imaging, by focusing on the exact forms of tissue which are more likely to be cancerous.
Transforming Breast Cancer Detection
Advance for Imaging & Radiation Oncology
PEM shows promise for initial staging of breast cancer, evaluating response to therapy, recurrence, and restaging.
CE mark expands Naviscan breast PET to 13 countries
Medical Device Daily
Naviscan (San Diego), a developer of organ-specific molecular imaging, has obtained CE mark approval for both its high-resolution PET scanner and PET-guided biopsy accessory.
Positron Emission Mammography in breast cancer: correlation between prognostic indicators and FDG Uptake
Diagnostic Imaging Europe
Published in the September issue of the American Journal of Roentgenology, researchers from the Swedish Cancer Institute and the University of Washington showed that using Positron Emission Mammography (PEM) they found a correlation between FDG uptake values and the prognostic factors that predict breast cancer survival.
Imaging Advances Breast Cancer Care
Dr. Michael Kinney discusses Positron Emission Mammography (PEM) for breast cancer surgical planning.
Study: PEM May Help Predict Breast Cancer Survival by IDing Most Aggressive Cancers
Advance for Imaging & Radiation Oncology
AJR: PEM FDG uptake values provide prognostic clues
18F-FDG uptake values measured by positron emission mammography (PEM) correlated with prognostic indicators that predict breast cancer survival and inform clinical management, including receptor status, tumor histology and tumor grade, according to a study published in the August issue ofAmerican Journal of Roentgenology.
NBC Coverage: New Hope for Breast Cancer Patients
Local doctors say the PEM scanner can reduce unnecessary biopsies.
Positron Emission Mammography is coming to Europe
Every medical congress is an opportunity for manufacturers to showcase their products. This year’s congress of the German Röntgen Society was no exception – and one innovation particularly caught the attention of our European Hospital team: positron emission mammography, PEM for short.
Positron Emission Mammography (Breast PET) Medical Products Asia
Medical Products Asia
Naviscan has two PET scanners currently installed in Asia (one in Yokohama, Japan and the other in Seoul, Koera), with distributors in South Korea, Hong Kong, Thailand, Malaysia, and Singapore.
The Naviscan PEM Scanner
The Naviscan PEM scanner is an optimized PET scanner designed to provide unprecedented metabolic visualization of small body parts.
Positron Emission Mammography (Breast PET)
The Naviscan PEM scanner is an optimised PET scanner designed to provide unprecedented metabolic visualization of small body parts. Through a unique combination of gentle immobilization, advanced photonics, and image processing, this scanner provides tomographic images with resolution down to 2 mm.
State-of-the-Art Women's Imaging
University Radiology Associates, LLP in Syracuse, NY, is pleased to bring positron emission mammography (PEM) to the Central New York area.
AJR: PEM Studies Emphasize Ease of Use
The American Journal of Roentgenology has published two separate studies this month demonstrating the clinical acceptance of Naviscan’s Positron Emission Mammography (PEM) scanner.
BI-RADS-like Lexicon Aids PEM Interpretation
Positron emission mammography (PEM) lends itself to standardized terminology for describing exam results, much like the BI-RADS lexicon for breast MRI. But there are key differences clinicians need to be aware of, advised researchers this month in the American Journal of Roentgenology.
Tech Trends: Breast Imaging Trade-Offs
With new approaches to breast cancer detection, there is a trade-off. PEM can be a good alternative to do for pre- and post-treatment.
PET-Guided Breast Biopsy Safe and Effective
Prospective data confirming the technical validity of image-guided needle biopsy of suspicious breast cancer lesions using Positron Emission Mammography (PEM) guidance has been published in the March/April issue of the Breast Journal.
Positron Emission Mammography Shows Promise in Breast Cancer
Positron emission mammography demonstrated equal sensitivity and a trend toward increased sensitivity compared with MRI in identifying contralateral breast cancer, according to findings presented at the 21st Annual National Interdisciplinary Breast Center Conference.
The Radiologist's View: PET and PEM
absolutely! KATY Magazine
THE RADIOLOGIST’S VIEW: PEM is not a screening tool to search for breast cancer. Rather, PEM is for patients who have already been diagnosed with breast cancer. For instance, with PEM, your radiologist may be able to notify your surgeon that there is a second smaller tumor next to the one which has already been diagnosed. This type of information might affect surgical planning and might alter the type of treatment which is best for you.
Hologic, GE and Naviscan Lead Breast Imaging and Digital Mammography in $2.3 Billion Women's Health Market
iData Research Inc.
According to a new report by iData Research, the leading authority in medical device and pharmaceutical market research, the U.S. breast imaging and mammography markets are expected to recover from the economic recession and almost double in value by 2017, reaching over $1 billion. Growth will be driven by the replacement of older analog mammography equipment by new technologies such as digital radiography, breast-specific gamma imaging (BSGI), positron emission mammography (PEM) and ultrasound equipment. Adoption of these technologies will drive the overall women's health market.
NBC News Coverage: PEM Saves Patient from Unnecessary Mastectomy
nbc4i.com - Columbus, OH
PEM, the latest to the fight against breast cancer, has come to the Breast Health Center at Riverside Methodist Hospital in Columbus, Ohio. Since PEM provides higher specificity than other imaging tools, it helps reduce false positives and can dramatically change treatment options. Hear the story of one patient whose surgeon initially decided mastectomy was her best option based on MRI findings. However, given its greater specificity, PEM showed a smaller extent of disease and she was able to undergo a lumpectomy instead.
Radiology: PEM complements MR, but gaps remain HealthImaging.com
A multicenter prospective study of positron emission mammography (PEM) and breast MR published in the January issue of Radiology found that PEM provided breast-level sensitivity comparable to breast MR, while MR delivered greater lesion-level sensitivity. PEM also demonstrated superior specificity and PPV as compared to MR.
Dr. Wendie Berg named Most Influential Radiology Researcher by AuntMinnie.com
Minnies candidates are nominated by AuntMinnie.commembers in September of each year. Semifinalists and finalists are selected through a vote by AuntMinnie's expert panel of editors and radiology professionals.
SNM Responds to Article in the New York Times
Society of Nuclear Medicine
On August 30, 2010, Dominique Delbeke, M.D., Ph.D., president of SNM, and Michael M. Graham, Ph.D., M.D., immediate past president of SNM, submitted a letter to the editor of The New York Times in order to express concern concerning the depiction of nuclear medicine in an August 24 article.
Breast PET scans now available at TEPAS Breast Center
TEPAS Breast Center
TEPAS Breast Center, a comprehensive breast screening, diagnostic and treatment facility, is Brevard’s first facility to offer positron emission mammography (PEM) imaging services.
EU funds clinical software research to detect breast cancer
The European Union (EU) has invested EUR3.1 million ($3.97 million U.S.) through the HAMAM project for developing clinical software tools that integrate imaging and quantitative data and combine it with personalized risk profiles for developing breast cancer, based on genetic information and family history.
Technology update: PET
For a nuclear medicine imaging modality as sophisticated as PET and PET/CT, new products and enhancements to existing systems come from customer feedback on everything from functionality to image quality, and the need for cost-effective imaging solutions.
A conversation with Wendie Berg, MD, PhD
PEM compares favorably to breast MRI for secondary disease
Breast MRI is considered the gold standard in breast imaging. But new data from a National Institutes of Health-sponsored, multi-site study of approximately 400 women with newly diagnosed breast cancer shows that positron emission mammography (PEM) may reduce unnecessary breast biopsies. The study found that PEM was significantly more precise at identifying benign and cancerous lesions, known as positive predictive value (PPV). As a result, clinicians may be able to reduce unnecessary biopsies.
Is PET a rival to breast MRI?
DotMed Business News
An ACRIN 6666 study published in the January issue of the Journal of Roentgenology found that 16 percent of women were unable to tolerate a breast MRI exam for reasons such as claustrophobia, metal implants or allergies to the MRI contrast agents. But such women can turn to another imaging modality, a PET scanner.
New tools for earlier breast cancer diagnosis
Modern techniques for investigating suspected breast cancer are now complementing conventional mammography. A team of European and US researchers is developing ways to combine all this data to help doctors make earlier and more accurate diagnoses.
PEM scanners may reduce unnecessary breast biopsies
Imaging Technology News
Positron emission mammography (PEM) may reduce unnecessary breast biopsies, according to new data from a National Institutes of Health (NIH)-sponsored, multisite study of hundreds of women with newly diagnosed breast cancer.
PET mammography reduces unnecessary biopsies
Positron-emission mammography may reduce unnecessary breast biopsies, according to data from an NIH-sponsored multisite study.PEM demonstrated a 6% improvement in specificity compared with breast MR, according to the research.
Breast care center finds success with same-day service
Our primary care physicians have welcomed this flow pattern, knowing their patients will be shepherded through the system in a consistent and secure fashion. As many mammographers feel overwhelmed with the “primary care” demands of the mammography population, these breast health specialists welcome the business and are very well-suited to provide clinical information for patients at all phases of a woman’s life.
Early Detection of Breast Tumors is Goal of University of Cincinnati Study
University of Cincinnati
A new study at UC Health University Hospital involving technology that is not being used anyplace else in Cincinnati may help specialists find breast tumors in the earliest stages and biopsy them at the time of detection.